Childhood acute lymphoblastic leukemia (ALL) is frequently initiated in utero at a time of developmentally regulated insertion of N regions into the DJH rearrangements of immunoglobulin heavy-chain (IgH) genes. Here it is shown that N regions are present in the clonotypic DJH rearrangements in 11 of 12 infant ALLs with t(4;11). These data are compared with the 122 previously published DJH sequences and were found to have a pattern similar to that of ALL in children older than 3 years at diagnosis but were unlike that in children younger than 3 years who predominantly lack N regions. These findings, therefore, indicate that t(4;11)-positive infant ALL is initiated later in fetal development than most B-cell precursor ALL from children younger than 3 years and that they have a shorter latency period already in utero.

Childhood acute lymphoblastic leukemia (ALL) is a heterogeneous group of leukemias with a predominance of the B-cell precursor (BCP) phenotype. A minority of these leukemias is associated with a translocation involving the mixed-lineage leukemia (MLL) gene on chromosome 11q23 that is fused, in 50% of patients, to the AF4 gene on chromosome 4q21.1The chromosomal translocation t(4;11)(q21;q23) occurs mostly in infant ALL and confers a dismal prognosis in this age group, whereas in older children and adults the prognosis does not differ from t(4;11)-negative cases.2,3 Differences in the chromosomal breakpoints of the MLL gene between infants and children or adults with t(4;11) ALL suggest different mechanisms for the development of these instances of ALL4 and, thus, their different biologic functions.

Greaves5 proposed a 2-step model for the development of ALL with an initiating event in utero, followed by a second mutation leading to overt leukemia. Indeed, leukemia-specific chromosomal translocations and clonotypic antigen-receptor gene rearrangements at birth recently confirmed the initiation of childhood ALL in utero.6-9 Thus, depending on the time of clinical manifestation, the latency period varies among the different types of leukemia. In contrast to leukemias with long latency periods for which a chromosomal translocation and additional postnatal mutations are required,9 the extremely short latency periods in infant ALL (with MLL rearrangements) suggest only limited further mutagenic requirements.1 It seems likely that not only postnatal but also prenatal development of the disease is rapid.

Assuming that the gene fusion resulting from t(4;11) in infant ALL is indeed an initiating event, its origin must be restricted to a period between the beginning of B lymphopoiesis in the fetal liver—ie, the 6th gestational week10—and possibly a few months before the diagnosis of leukemia.11 This translocation is assumed to occur in a cell that has already started to rearrange its IgH genes. The time period of these rearrangement processes during fetal development can be determined by the presence or absence of N regions between the DJH joinings. The addition of N nucleotides requires terminal deoxynucleotidyl transferase (TdT) that is not initially present in fetal lymphopoiesis but that has been observed by the end of the first trimester of gestation.12-14 

We therefore used the leukemia clone-specific junctional regions of DJH rearrangements to determine the time point of a first mutation in utero in t(4;11) ALL in infancy. We show the presence of N regions between the DJH joinings in 11 of 12 infant ALLs with t(4;11) indicating their initiation at a later time during fetal development than most other leukemias that become apparent during the first 3 years of life.

The occurrence of t(4;11) ALL was analyzed in 13 infants. Inclusion criteria were patient age younger than 1 year at diagnosis and the presence of at least one clonotypic IgHrearrangement (Figure 1). All leukemias had a pro B phenotype with frequent coexpression of myeloid markers. The local institutional ethical committee approved the study, and informed consent was obtained from the parents.

Fig. 1.

Nucleotide sequence of IgH rearrangements in t(4;11) infant ALL.

Trimming of the rearranged segments is indicated by the numbers of nucleotides. N nucleotides between DD segments are shown in italics; shaded areas indicate sequence homology between 2 rearrangements.

Fig. 1.

Nucleotide sequence of IgH rearrangements in t(4;11) infant ALL.

Trimming of the rearranged segments is indicated by the numbers of nucleotides. N nucleotides between DD segments are shown in italics; shaded areas indicate sequence homology between 2 rearrangements.

Close modal

DNA was extracted from cells by standard procedures.15Amplification of the ret-oncogen confirmed the integrity of DNA in all samples. Clonal IgH rearrangements were determined by VH-family–specific and JH consensus primers for the amplification of V(D)JH rearrangements and of primer sets for the amplification of all incomplete DJHrearrangements, as described previously.16 17 Amplified products were sequenced directly, and involved gene segments were identified by BLAST sequence similarity searches (http://www.ncbi.nlm.nih.gov/BLAST/) and by comparison with published sequences of all known human immunoglobulin genes (http://www.ebi.acc.uk), allowing the assignment of nucleotides to either the V, D, and J regions or to the P and N regions by exclusion.

We identified 16 IgH rearrangements in 13 infants with t(4;11) ALL (Figure 1A). Ten leukemias had 1 rearrangement, and 3 leukemias (patients 4, 8, 10) had 2 rearrangements. We considered only 1 of the 2 rearrangements (in patients 4 and 10) because they had identical DJH regions. We excluded the DJHrearrangement in patient 1 because the sequence between DHand JH was homologous to the J1 pseudogene. Thus, 13 unique rearrangements were analyzed for the inclusion of N regions. We observed in patient 4 a D-D fusion, but only the DHgene segment most proximal to the JH segment was included in the analysis. As depicted in Figure 1, only 1 of the 13 unique sequences lacked N regions at the DJH junction. The results from this study are compared with those from 122 previously published cases (Table 1). It appears that the lack of N regions in t(4;11) infant ALL is less common than in children with ALL who are younger than 3 years at diagnosis but that they are about as common as in children older than 3 years.15,18,19Figure 1 illustrates the use of DH and JHfamilies, similar to that reported previously.16,18 19 

The data from this study indicate that most DJH regions from infant ALL with t(4;11) contain N nucleotides that developed at a time of TdT activity; hence, they were more mature than those without N regions. Interestingly, other leukemias, diagnosed in children before the age of 3, do not have N regions in their DJHjunctions15,18,19 and thus have a longer latency period than the t(4;11) infant leukemias. There are 2 groups of BCP ALL that have N regions in their clonotypic DJH junctions, namely t(4;11) infant ALL with a manifestation mostly in the first year of life and other leukemias with a clinical manifestation after the 3rd year of life.18 19 Both rearrange their DJHsegments at a similar time during gestational development. It is obvious, however, that t(4;11) ALL has a remarkably shorter latency than the others.

We propose a model for the relation between the time of initiation of the leukemia, characterized by the clonotypic DJHrearrangements, and the age of the children at clinical manifestation of BCP ALL (Figure 2). IgHrearrangements that lack N regions occur during a narrow time window—the first weeks of B lymphopoiesis in fetal liver that is TdT negative. Transformed cells with such rearrangements most likely acquire additional mutations, leading to leukemias during the first 3 years of life. IgH rearrangements with the addition of N nucleotides in the DJH junction occur later in gestation, when TdT has already been activated. These leukemias become clinically apparent during the first year of life if a t(4;11) chromosomal translocation started leukemogenesis or, in its absence, after the 3rd year of life. Alternatively, the t(4;11) translocation arises in a TdT-negative primitive cell without IgH rearrangements. This target cell may represent a B-plus myeloid lymphoid stem cell, as described by Cumano et al20 in mouse fetal liver, which would be unique in specific stages of in utero hematopoiesis. The N region–positive DJH rearrangement may be a later addition during progression to leukemia. Then, unrelated rearrangements are expected, such as in t(9;22) B lymphoid blast crisis of chronic myeloid leukemia.16 However, in our series, no leukemia had multiple unrelated IgH rearrangements, but 2 leukemias had related rearrangements. In addition, the target cell for the t(4;11) translocation may be a rare progenitor with TdT expression at earlier stages of fetal lymphopoiesis than common B precursor cells. No such cells have been identified thus far in humans.

Fig. 2.

Time frame.

Development of N− and N+ BCP leukemias in childhood.

Fig. 2.

Time frame.

Development of N− and N+ BCP leukemias in childhood.

Close modal

It is assumed that a chromosomal translocation is an initiating event in leukemogenesis,9,21 which can be induced by apoptotic stimuli that lead to the generation of gene fusions in B precursor cells, thus rescuing a cell programmed to die.22 This assumption is supported by the findings that most IgHrearrangements in ALL are either incomplete or not potentially productive,16 underlining the immaturity of these cells, which would not survive without a transformation. It is further hypothesized that additional mutations are required for the development of leukemia. However, our findings support the hypothesis that the t(4;11) is either sufficient for leukemogenesis or provokes efficiently further changes that lead eventually to leukemia in infancy.1 11 

This article is dedicated to Helmut Gadner for his 60th birthday.

Supported in part by the Österreichische Kinderkrebshilfe and by a grant from the Deutsche Krebshilfe (Bo 10-124.3).

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

1
Dimartino
JF
Cleary
ML
MLL rearrangements in haematological malignancies: lessons from clinical and biological studies.
Br J Haematol.
106
1999
614
626
2
Dordelmann
M
Reiter
A
Borkhardt
A
et al
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
Blood.
94
1999
1209
1217
3
Biondi
A
Cimino
G
Pieters
R
Pui
CH
Biological and therapeutic aspects of infant leukemia.
Blood.
96
2000
24
32
4
Reichel
M
Gillert
E
Angermüller
A
et al
Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL.
Oncogene.
20
2001
2900
2907
5
Greaves
M
A natural history of pediatric acute leukemias.
Blood.
82
1993
1043
1051
6
Gale
KB
Ford
AM
Repp
R
et al
Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots.
Proc Natl Acad Sci U S A.
94
1997
13950
13954
7
Fasching
K
Panzer
S
Haas
OA
Marschalek
R
Gadner
H
Panzer-Grümayer
ER
Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia.
Blood.
95
2000
2722
2724
8
Yagi
T
Hibi
S
Tabata
Y
et al
Detection of clonotypic IgH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia.
Blood.
96
2000
264
268
9
Wiemels
JL
Cazzaniga
G
Daniotti
M
et al
Prenatal origin of acute lymphoblastic leukemias in children.
Lancet.
354
1999
1499
1503
10
Gathings
WE
Lawton
AR
Cooper
MD
et al
Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans.
Eur J Immunol.
7
1977
804
810
11
Greaves
M
Molecular genetics, natural history and the demise of childhood leukemia.
Eur J Cancer.
35
1999
173
185
12
Bodger
MP
Janossy
G
Bollum
FJ
Burford
GD
Hoffbrand
AV
The ontogeny of terminal deoxynucleotidyl transferase positive cells in the human fetus.
Blood.
61
1983
1125
1131
13
Raaphorst
FM
Timmers
E
Kenter
MJ
Van Tol
MJ
Vossen
JM
Schuurman
RK
Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements.
Eur J Immunol.
22
1992
247
251
14
Cuisinier
AM
Gauthier
L
Boubli
L
Fougereau
M
Tonnelle
C
Mechanisms that generate human immunoglobulin diversity operate from the 8th week of gestation in fetal liver.
Eur J Immunol.
23
1993
110
118
15
Schneider
M
Panzer
S
Stolz
F
Fischer
S
Gadner
H
Panzer-Grümayer
ER
Crosslineage TCR delta rearrangements occur shortly after the DJ joinings of the IgH genes in childhood precursor B ALL and display age-specific characteristics.
Br J Haematol.
99
1997
115
121
16
Height
SE
Swansbury
GJ
Matutes
E
Treleaven
JG
Catovsky
D
Dyer
MJS
Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia.
Blood.
87
1996
5242
5250
17
Szczepanski
T
Pongers-Willemse
MJ
Langerak
AW
et al
Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6–19 and DH7–27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor ab lineage.
Blood.
93
1999
4079
4085
18
Wassermann
R
Galili
N
Yoshinori
Y
Reichard
BA
Shane
S
Rovera
G
Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event.
J Exp Med.
176
1992
1577
1581
19
Steenbergen
EJ
Verhagen
OJHM
Van Leuwen
EF
et al
B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life.
Eur J Immunol.
24
1994
900
908
20
Cumano
A
Paige
CJ
Iscove
N
Brady
G
Bipotential precursor B cells and macrophages in murine fetal liver.
Nature.
356
1992
612
615
21
Wiemels
JL
Ford
AM
Van Wering
ER
Postma
A
Greaves
M
Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero.
Blood.
94
1999
1057
1062
22
Stanulla
M
Wang
J
Chervinsky
DS
Thandla
S
Aplan
PD
DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.
Mol Cell Biol.
17
1997
4070
4079

Author notes

E. Renate Panzer-Grümayer, Children's Cancer Research Institute, St Anna Kinderspital, Kinderspitalgasse 6, A-1090 Vienna, Austria; e-mail: panzer@ccri.univie.ac.at.

Sign in via your Institution